Contribution: Industrial Research Assistance Program – Contributions to Firms
Mesentech Inc.
$413,500.00
Development and validation of a subcutaneous delivery formulation of a bone-healing therapeutic
FY 2021-22 · 2021-12-06
Summary
This project will help the firm develop, optimize and characterize a formulation of their lead therapeutic compound that is suitable for administration via subcutaneous injection. Efficacy of the new formulation will also be functionally validated.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
832032031
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-12-06 | 2021-22 | $313,500.00 |
| 1 | 2021-12-06 | 2021-22 | $413,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days. The total amended value is 100,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 90 jours. La valeur totale des modifications est de 100 000 dollars.
Agreement End Date
2023-03-31
Agreement Number
985072
Agreement Start Date
2021-12-06
Agreement Title
Development and validation of a subcutaneous delivery formulation of a bone-healing therapeutic
Agreement Title (French)
Mise au point et validation d'une formulation pour l'administration sous-cutanée d'une thérapie de guérison osseuse
Agreement Type
Contribution
Agreement Value
$413,500.00
Amendment Date
2023-01-09
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will help the firm develop, optimize and characterize a formulation of their lead therapeutic compound that is suitable for administration via subcutaneous injection. Efficacy of the new formulation will also be functionally validated.
Description (French)
Ce projet permettra à l'entreprise de développer, d'optimiser et de caractériser une formulation de leur principal composé thérapeutique qui convient à l'administration par injection sous-cutanée. L'efficacité de la nouvelle formulation sera également validée sur le plan fonctionnel.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
832032031
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Mesentech Inc.
Recipient Postal Code
V6T 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q4-985072
